# Neurocognitive Decline in Patients With Brain Metastases

> **NCT03508752** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT03508752
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-05
- **Primary completion:** 2026-04-13
- **Final completion:** 2027-11-13
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508752, "Neurocognitive Decline in Patients With Brain Metastases". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03508752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*